Companies sponsoring UK NEQAS ICC & ISH have no influence on methods, results or conclusions. UK NEQAS ICC & ISH is an independent organisation.
DAKO, now part of Agilent Technologies Inc. are a leading provider of complete pathology solutions trusted by histopathology laboratories around the world.
Our world-class IVD reagents plus fully automated instruments seamlessly linked to LIS/LIMS with slide and specimen tracking, helps to deliver quality staining and reduce unwanted errors.
Leica Biosystems – Advancing Cancer Diagnostics, Improving Lives
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow from biopsy to diagnosis.
Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Diaceutics provides strategic and educational services within the field of personalized medicine. Our work enables harmonized integration of diagnostic and therapeutic pathways, from the earliest stages of diagnostic test development through to laboratory integration. We provide data and insights to understand the diagnostic landscape and to highlight the importance of the diagnostic laboratory for accurate test implementation.
Menarini Diagnostics is able to offer a complete laboratory solution for Cellular Pathology. The Total Tissue Diagnostics™ ranges starts at specimen handling within theatres and then runs all the way through to digitally assisted diagnosis.
The range comprises innovative equipment and instrumentation together with a state-of-the-art LIMS and tracking software solution.
Roche is the world’s largest biotech company, with differentiated medicines in oncology, immunology, & infectious diseases. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics.
Roche’s personalised healthcare strategy aims at providing diagnostics that improvement the health, quality of life and survival of patients.